Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease.
Rovelet-Lecrux A, Legallic S, Wallon D, Flaman JM, Martinaud O, Bombois S, Rollin-Sillaire A, Michon A, Le Ber I, Pariente J, Puel M, Paquet C, Croisile B, Thomas-Antérion C, Vercelletto M, Lévy R, Frébourg T, Hannequin D, Campion D; Investigators of the GMAJ project. Rovelet-Lecrux A, et al. Among authors: bombois s. Eur J Hum Genet. 2012 Jun;20(6):613-7. doi: 10.1038/ejhg.2011.225. Epub 2011 Dec 14. Eur J Hum Genet. 2012. PMID: 22166940 Free PMC article.
[Treatment of Alzheimer's disease].
Bombois S, Lebert F, Vellas B, Pasquier F. Bombois S, et al. Rev Prat. 2005 Nov 15;55(17):1913-9. Rev Prat. 2005. PMID: 16396232 Review. French.
Biochemistry of Tau in Alzheimer's disease and related neurological disorders.
Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, Bombois S, Blum D, Delacourte A, Pasquier F, Vanmechelen E, Schraen-Maschke S, Buée L. Sergeant N, et al. Among authors: bombois s. Expert Rev Proteomics. 2008 Apr;5(2):207-24. doi: 10.1586/14789450.5.2.207. Expert Rev Proteomics. 2008. PMID: 18466052 Review.
[Biological markers in Alzheimer disease: what are the chances for less slow diagnosis?].
Schraen-Maschke S, Dhaenens CM, Bombois S, Deramecourt V, Van Brussel E, Obriot H, Marzys C, Sergeant N, Maurage CA, Pasquier F, Sablonnière B, Buée L. Schraen-Maschke S, et al. Among authors: bombois s. Rev Neurol (Paris). 2009 Apr;165 Spec No 2:F97-103. Rev Neurol (Paris). 2009. PMID: 19593884 Review. French. No abstract available.
[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].
Buée L, Blum D, Bombois S, Buée-Scherrer V, Caillet-Boudin ML, Colin M, Deramecourt V, Dhaenens CM, Galas MC, Hamdane M, Humez S, Maurage CA, Pasquier F, Sablonnière B, Schraen-Maschke S, Sergeant N. Buée L, et al. Among authors: bombois s. Therapie. 2010 Sep-Oct;65(5):401-7. doi: 10.2515/therapie/2010054. Epub 2010 Dec 13. Therapie. 2010. PMID: 21144474 French.
123 results